Ads
related to: congenital adrenal hyperplasia treatments in dogs
Search results
Results from the WOW.Com Content Network
Alopecia X is a type of adult-onset follicular dysplasia in dogs previously known by many other names. The condition was first described in 1977. The condition was first described in 1977. The condition is believed to be caused by a genetic predisposition to a hormone defect.
In the United States, congenital adrenal hyperplasia in its classic form is particularly common in Native Americans and Yupik Inuit (incidence 1 ⁄ 280). Among American Caucasians, the incidence of the classic form is about 1 ⁄ 15,000). [24] Continued treatment and wellness are enhanced by education and follow up. [35]
The outcomes and prognosis for CAH (Congenital Adrenal Hyperplasia) can vary depending on several factors, such as the specific type of CAH, its severity, early detection, and proper management. With appropriate medical care and ongoing treatment, individuals with CAH can lead healthy lives.
It is also being trialed in humans to study its efficacy in treatment of breast cancer in women, [9] and in treating precocious puberty and congenital adrenal hyperplasia in male and female children. [10] As of August 2011 this drug was not approved for general use outside the FDA-licensed functions in the U.S., other than within approved ...
Without treatment, an adrenal crisis can result in death. [1] Addison's disease affects about 9 to 14 per 100,000 people in the developed world. [1] [3] It occurs most frequently in middle-aged females. [1] The disease is named after Thomas Addison, a graduate of the University of Edinburgh Medical School, who first described the condition in 1855.
Congenital adrenal hyperplasia is an autosomal recessive disorder with multiple types, two of which lead to pseudohyperaldosteronism. [1] Deficiency of 11-beta-hydroxylase blocks the conversion of 11-deoxycorticosterone (DOC) to corticosterone leading to an excess of DOC which acts as a mineralocorticoid similar to aldosterone.
Late onset congenital adrenal hyperplasia (LOCAH), also known as nonclassic congenital adrenal hyperplasia (NCCAH or NCAH), is a milder form of congenital adrenal hyperplasia (CAH), [1] a group of autosomal recessive disorders characterized by impaired cortisol synthesis that leads to variable degrees of postnatal androgen excess. [1] [2] [3] [4]
Congenital adrenal hyperplasia due to 17α-hydroxylase deficiency is an uncommon form of congenital adrenal hyperplasia (CAH) resulting from a mutation in the gene CYP17A1, which produces the enzyme 17α-hydroxylase. [1] [2] It causes decreased synthesis of cortisol and sex hormones, with resulting increase in mineralocorticoid production.
Ads
related to: congenital adrenal hyperplasia treatments in dogs